13 Jul 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide A/S: Change of report date

Press release

November 25, 2019

FluoGuide A/S will publish its interim report for third quarter 2019 on 29 November 2019. Previously communicated date was 30 November 2019.

30 November is a Saturday and the report date is therefore changed to Friday, 29 November 2019.


For further information, please contact:
Morten Albrechtsen, CEO
Telephone: +45 24 25 62 66